Wu, Y.; Zhang, X.; Duan, X.; Yang, X.; Wang, F.; Zhang, J.
Optimized Therapeutic 177Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer. Pharmaceuticals 2022, 15, 1530.
https://doi.org/10.3390/ph15121530
AMA Style
Wu Y, Zhang X, Duan X, Yang X, Wang F, Zhang J.
Optimized Therapeutic 177Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer. Pharmaceuticals. 2022; 15(12):1530.
https://doi.org/10.3390/ph15121530
Chicago/Turabian Style
Wu, Yitian, Xiaojun Zhang, Xiaojiang Duan, Xing Yang, Feng Wang, and Jinming Zhang.
2022. "Optimized Therapeutic 177Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer" Pharmaceuticals 15, no. 12: 1530.
https://doi.org/10.3390/ph15121530
APA Style
Wu, Y., Zhang, X., Duan, X., Yang, X., Wang, F., & Zhang, J.
(2022). Optimized Therapeutic 177Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer. Pharmaceuticals, 15(12), 1530.
https://doi.org/10.3390/ph15121530